RELMADA THERAPEUTICS, INC. (RLMD) Operating cash flow 2016–2025
RELMADA THERAPEUTICS, INC. (RLMD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$45.8MFY2025 · since FY2016: -$13.1M → -$45.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.8M | +11.5% |
| FY2024 | -$51.8M | -0.2% |
| FY2023 | -$51.7M | +50.2% |
| FY2022 | -$103.8M | -13.0% |
| FY2021 | -$91.9M | -230.4% |
| FY2020 | -$27.8M | -130.0% |
| FY2019 | -$12.1M | -101.5% |
| FY2018 | -$6.0M | +7.2% |
| FY2017 | -$6.5M | +50.8% |
| FY2016 | -$13.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice